WASHINGTON D.C., May 17, 2024
/CNW/ -- HOYA Group Company, PENTAX
of America, Inc. (PENTAX Medical) and MAGENTIQ-EYE Ltd., an AI
medical device company, announced today their intention to form a
partnership in the field of AI in Gastroenterology and to examine
further collaboration and strategic partnerships.
Pending field trials and customer demonstrations to be conducted
over the next several months, the companies expect to formalize an
agreement as a first step in this partnership, by which PENTAX
Medical will distribute the MAGENTIQ-COLO™ AI-assisted lesion
detection device in the U.S.A.
beginning October 1st, 2024. The
system will be demonstrated at the upcoming Digestive Disease Week
(DDW) in Washington D.C., U.S.A.
MAGENTIQ-COLO™ is a cutting-edge system for the detection of
gastrointestinal lesions in colonoscopies. Successfully validated
in an international multicenter, randomized, controlled trial (RCT)
with 950 enrolled patients at 10 hospitals in Europe, United
States and Israel, its
outstanding diagnostic capabilities are setting new standards in
endoscopic AI.
"We are excited to bring the MAGENTIQ-COLO™ device to the GI
community in the U.S. Together with PENTAX Medical's product
portfolio, we are confident to provide a smart solution in
colonoscopy and contribute further to colorectal cancer
prevention", says David Harrison,
President PENTAX of America, Inc.
"Partnering with PENTAX Medical is an important milestone for
us, as it opens new opportunities to introduce our game changing
product to the U.S. market, benefiting doctors and their patients
and saving more lives", says Dror
Zur, Founder & CEO of MAGENTIQ-EYE.
About MAGENTIQ-EYE Ltd.
Founded in 2014, MAGENTIQ-EYE
offers a groundbreaking AI-aided colonoscopy solution that offers
one of the best performances known today. With worldwide
recognition from the gastroenterology community, and dozens of
procedures performed every day with the assistance of
MAGENTIQ-COLO™, we are setting the new standard of colonoscopy, and
saving more and more lives. www.magentiq.com
About PENTAX Medical
PENTAX Medical is a division of HOYA Group. The company's
mission is to improve the standard of patient care and quality of
healthcare delivery by providing the best endoscopic products and
services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION,
and SIMPLICITY. PENTAX Medical strives to align with the healthcare
community's Triple Aim goals through transparent partnerships with
its customers and by providing the highest quality solutions to
help them reach their goals, including enabling customers to
improve patient outcomes by offering evidence-based solutions
across the continuum of care; ensuring value by supporting the
customers to improve their efficiency and minimize their healthcare
costs; and enriching patient and provider's experience by
empowering every member of the care team to achieve optimal
outcomes through products, education, and support. Focused on the
outcome instead of technological features, PENTAX Medical listens
to the healthcare community and their patients, understands their
daily obstacles and helps improve endoscopy with smart
innovations.
For more information: https://www.pentaxmedical.com
About HOYA
Founded in 1941 in Tokyo,
Japan, HOYA Corporation is a global technology and med-tech
company and a leading supplier of innovative high-tech and medical
products. HOYA is active in the fields of lifecare and information
technology, providing eyeglasses, medical endoscopes, intraocular
lenses, optical lenses, as well as key components for semiconductor
devices, LCD panels, and hard disk drives. With over 150 offices
and subsidiaries worldwide, HOYA currently employs a multinational
workforce of 36,000 people. For more information, please visit:
https://www.hoya.com/en/
View original
content:https://www.prnewswire.com/news-releases/hoya-group-company-pentax-of-america-inc-and-magentiq-eye-ltd-announce-their-intention-to-form-a-distribution-partnership-for-the-us-market-302148967.html
SOURCE HOYA Corporation PENTAX Medical